Latest Current Report
Filed: 2026-05-08
Key Insights
- Baxter approved a new Executive Severance and Change in Control Plan effective May 4, 2026, which supersedes the prior plan and expands severance protections by including resignations for 'Good Reason' and clarifying that position eliminations constitute qualifying terminations.
- CEO Andrew Hider's offer letter was amended to increase healthcare coverage payments from 18 to 24 months in non-change-of-control terminations, signaling potential executive retention concerns or competitive market pressures for leadership talent.
- The new plan maintains tiered severance structures with enhanced CIC protections (2.0x multiplier for most executives, 1.5x for interim CFO Zielinski post-promotion) and includes restrictive covenants but notably excludes excise tax gross-ups, which could reduce total severance liabilities.
- Interim CFO Anita Zielinski receives preferential treatment with reduced multipliers upon ceasing interim duties, suggesting an anticipated transition in CFO responsibilities that may signal organizational restructuring or permanent appointment timeline.